Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
for
Solid Tumors, Gastric Cancer,
Location: Santa Monica CA, Santa Rosa CA, Washington D.C. DC,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT06710132
Phase1, Phase2, Recruiting
Active & Responsive
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Orange CA, Chicago IL, Westwood KS, New York NY,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase1, Recruiting
Active & ResponsiveNew
IKS014 in Advanced Solid Tumors That Express HER2
for
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Location: Newport Beach CA, Boston MA, Nashville TN
Sponsor: Iksuda Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT05872295
Phase1, Recruiting
Active & Responsive
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
for
Gastric Cancer
Location: Los Angeles CA, Boston MA, East Brunswick NJ
Sponsor: Idience Co., Ltd.
Sex: All
Age: 18+
Code: NCT04725994
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Houston TX, Irving TX, Fairfax VA
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase1, Recruiting
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,